ArticleMolecular cancer therapeutics2023

First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma.

Erika P Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.